Arie Belldegrun - 31 Mar 2025 SCHEDULE 13G/A Report for Allogene Therapeutics, Inc. Common Stock (ALLO)

Filing Manager
Arie Belldegrun
Reporting Manager
Arie Belldegrun, M.D.
Security
Allogene Therapeutics, Inc. Common Stock
Symbol
ALLO
Shares outstanding
220,060,421 shares
Disclosed Ownership
12,543,444 shares
Ownership
5.7%
Form type
SCHEDULE 13G/A
Filing time
09 May 2025, 17:30:51 UTC
Date of event
31 Mar 2025
Previous filing
13 Feb 2025
Next filing
12 Aug 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Arie Belldegrun, M.D. 5.7% 12,543,444 3,771,157 8,772,287 /s/ Arie Belldegrun Arie Belldegrun, M.D.
Bellco Legacy LLC 0.2% 539,867 0 539,867 /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Bellco Legacy IV LLC 2.1% 4,710,120 0 4,710,120 /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Vida Ventures LLC 0.8% 1,798,163 0 1,798,163 /s/ Arie Belldegrun By VV Manager LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,
Vida Ventures III, L.P. 0.8% 1,720,172 0 1,720,172 /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,
Vida Ventures III-A, L.P. 0% 3,965 0 3,965 /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,